AWL
Expansion of Tech-enabled, on-demand supply chain
CURRENT IMPACT
As on November 2022
31, 000 +
Supplied oxygen concentrators & 21,200+ oxygen cylinders
11000+
Supplied ventilators and 4M+ masks & PPE kits
2 Lac +
Remdesivir injections supplied
Geographical Focus
- PAN India
Potential Impact
- Reach
80 Million
lives
Rahul Mehra CEO and Founder, AWL India
During the second wave of COVID-19, we were on the frontline, managing the oxygen shortage throughout the country through our tech-based and fast-paced logistics solutions. At this time, SAMRIDH provided us the opportunity to secure additional commercial capital and savings, through partial risk guarantee, without blocking the available funds. This support and partnership provided by SAMRIDH has helped us to fast-track and scale up our operations to meet the evolving demands in the light of the COVID-19 pandemic.
Samridh support
SAMRIDH has supported AWL in covering the operational expenses for the expansion of temperature-controlled warehouses. Using the cash collateral secured through SAMRIDH as a partial risk guarantee, AWL was able to secure additional commercial capital without blocking its own funds. Further, the savings realised by AWL through SAMRIDH’s partial risk guarantee was used to support the capital expenditure of the business leading to the expansion of their operations.
25
%
of all vaccines in India are wasted due to compromised cold-chain management practices [1]
76
%
of vaccine vials tested indicated signs of freezing[2]
In April-June 2021, when the number of COVID-19 cases spiked suddenly and exponentially, it was quickly realised that fast and complete vaccination would be the only endgame for this pandemic. While vaccines were being manufactured at accelerated speeds, administering an injectable vaccine to the eligible adult population across the length and breadth of our vast country seemed like an onerous and insurmountable challenge. Most of the COVID-19 vaccines being distributed in India require some form of cold storage, and even a single transport leg or storage port that isn’t temperature-controlled puts the potency of the vaccine at risk, even rendering it ineffective.
AWL India, one of the leading providers of supply chain solutions to the Indian government, has developed a seamless pan-India network of temperature-controlled warehouses to ensure equitable delivery of COVID-19 equipment and other medical supplies. AWL’s collaboration with SAMRIDH has enabled expansion of the cold storage supply chain to serve 70+ tier2 and 3 cities across the country. As of November 2022, AWL has delivered 31,000+ oxygen concentrators, 11000+ ventilators and 4 million+ masks and PPT kits for COVID-19 mitigation across the country.
Through SAMRIDH’s support, AWL has expanded its services beyond vaccines and is also providing warehousing facilities for other medical relief material like ventilators, oxygen machines, medicines etc. For this, it has remodelled the end-to-end supply chain to fit the complete healthcare service range and not just vaccines and drugs. To enhance scale of operations for ensuring last-mile delivery, AWL has empanelled third-party distributors to penetrate hilly and tribal areas of northeast India that have low levels of logistic service penetration.
Key Stakeholders
